Indicators | Summary RR (95% CI) | p | I2 (%) |
---|---|---|---|
Total PUFA | 1.012 (0.992, 1.032) | 0.246 | 68.2 |
 Sensitivity analysis | 1.012 (0.992, 1.032) |  |  |
 Publication bias | Z = 2.46 | 0.014 |  |
Sex | |||
 Women | 1.049 (1.019, 1.079) | 0.001 | 77.1 |
 Men | 0.955 (0.913, 0.999) | 0.044 | 62.2 |
 Mixed | 0.984 (0.955, 1.013) | 0.269 | 41.2 |
Geographic location | |||
 United States | 1.011 (0.982, 1.041) | 0.467 | 78.2 |
 Europe | 1.040 (1.009, 1.072) | 0.012 | 54.8 |
 Australia | 1.188 (1.113, 1.269) | < 0.001 | 0.0 |
 Asia | 0.897 (0.860, 0.936) | < 0.001 | 45.4 |
Duration of follow-up, y | |||
 < 10 | 0.999 (0.968, 1.031) | 0.942 | 38.4 |
 ≥ 10 | 1.016 (0.991, 1.042) | 0.200 | 79.2 |
Exposure | |||
 PUFA | 0.979 (0.905, 1.058) | 0.588 | 63.7 |
 Omega-3 | 1.028 (0.987,1.070) | 0.183 | 69.0 |
 Omega-6 | 0.985 (0.942, 1.030) | 0.511 | 60.7 |
 ALA | 1.003 (0.966, 1.041) | 0.887 | 59.2 |
 EPA | 1.078 (0.965, 1.203) | 0.183 | 64.9 |
 DHA | 1.164 (1.048, 1.294) | 0.005 | 61.4 |
 EPA + DHA | 0.992 (0.926, 1.064) | 0.830 | 0.0 |
 LA | 0.956 (0.930, 0.983) | 0.001 | 40.4 |
 AA | 1.286 (0.964, 1.716) | 0.087 | 92.5 |